DHCR7 and hepatocellular carcinoma: Florencio Porto Freitas et al. used CRISPR/Cas9-mediated genome-wide screening to identify DHCR7 as a regulator of ferroptosis in hepatocytes, and inhibition of DHCR7 can reduce ferroptosis of human hepatocellular carcinoma cells [58].